*November 2021*
Listen to EGFR Resisters co-founder Jill Feldman’s presentation at ASTRO — innovating for clinically meaningful benefits that matter to patients. The final session of the symposium was a lively debate on randomized clinical trials versus real world data. Four speakers offered points/counterpoints for randomized clinical trials versus real world data, and Jill Feldman, a lung cancer patient advocate and survivor, provided her thoughts on this challenging topic. Watch it here.
